December 28, 2014 1:43 PM ET


Company Overview of Edge Therapeutics, Inc.

Executive Profile

Brian A. Leuthner

Co-Founder, Chief Executive Officer, President and Director, Edge Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships


Mr. Brian A. Leuthner is a Co-founder of Edge Therapeutics Inc. and serves as its Chief Executive Officer and President. Mr. Leuthner served as Marketing Executive in the hospital critical care marketplace growing hospital business units, products and customer bases for 22 years. Mr. Leuthner's entrepreneurial experience includes starting Fontus Pharmaceuticals as Chief Executive Officer. He served as Director of Market Development for start-up ESP Pharma. Mr. Leuthner ...

Corporate Headquarters

139 South Street
New Providence, New Jersey 07974

United States

Phone: 800-208-3343
Fax: 800-208-3433

Board Members Memberships

Co-Founder, Chief Executive Officer, President and Director


University Of North Carolina At Chapel Hill
University Of North Carolina At Chapel Hill

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Edge Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at